{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6123265",
  "DateCompleted": {
    "Year": "1982",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "08",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0002-9564",
      "JournalIssue": {
        "Volume": "36",
        "Issue": "1",
        "PubDate": {
          "Year": "1982",
          "Month": "Jan"
        }
      },
      "Title": "American journal of psychotherapy",
      "ISOAbbreviation": "Am J Psychother"
    },
    "ArticleTitle": "Treating depression in schizophrenic patients.",
    "Pagination": {
      "StartPage": "14",
      "EndPage": "22",
      "MedlinePgn": "14-22"
    },
    "Abstract": {
      "AbstractText": [
        "Successful intervention in the depressive reactions of schizophrenic patients depends on accurate diagnosis, careful observation, the use of many modalities of treatment, and the maintenance of therapist optimism. Therapy needs to be pragmatic and focused on the special needs of the individual patient."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Seeman",
        "ForeName": "M V",
        "Initials": "MV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "McGee",
        "ForeName": "H",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Psychother",
    "NlmUniqueID": "0110672",
    "ISSNLinking": "0002-9564"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antipsychotic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Delayed-Action Preparations"
    },
    {
      "RegistryNumber": "9FN79X2M3F",
      "NameOfSubstance": "Lithium"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Adjustment Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antipsychotic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Delayed-Action Preparations"
    },
    {
      "QualifierName": [
        "chemically induced",
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Lithium"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapy"
    },
    {
      "QualifierName": [
        "complications",
        "psychology"
      ],
      "DescriptorName": "Psychotic Disorders"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Schizophrenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Schizophrenic Psychology"
    }
  ]
}